DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidMLAMSRAFoundation

Optic neuritis

Essential points for quick revision.

!
Escalate

Any acute monocular visual loss requires same-day ophthalmic or stroke-pathway assessment. Profound or rapidly bilateral loss, marked disc swelling, haemorrhage, retinal findings, systemic giant-cell-arteritis symptoms, neurological decline or suspected infection needs emergency treatment and specialist input; steroid therapy must not be started casually before important infectious and ischaemic alternatives are considered.

Synopsis

Recognise an acute optic neuropathy, distinguish typical demyelinating optic neuritis from ischaemic, compressive, infectious and antibody-associated disease and coordinate urgent eye and neurological investigation.

  • Typical demyelinating optic neuritis usually causes subacute monocular visual loss over hours to days, pain worsened by eye movement, reduced colour saturation, a central or caecocentral field defect and a relative afferent pupillary defect.
  • The optic disc is often normal because inflammation is retrobulbar. A normal-looking disc does not exclude substantial optic-nerve dysfunction; marked swelling, haemorrhage or exudate is atypical and broadens the differential.
  • Measure corrected acuity in each eye, red or colour perception, pupils, confrontation fields and fundi. A binocular acuity result or vague statement that vision is blurred cannot localise the lesion.

Key red flags

Typical demyelinating optic neuritis

Subacute unilateral central visual loss, dyschromatopsia, eye-movement pain and a relative afferent pupil defect with a normal or mildly swollen disc in a younger adult supports typical optic neuritis.

Investigation priorities

01
Corrected acuity, colour, pupil and visual-field examinationFirst step

Confirm objective afferent dysfunction, quantify severity and provide a baseline for recovery.

Management branches

Acute monocular lossLocalise before assuming neuritis

Vision declines over minutes to days with pain, colour change, field loss or an afferent pupil defect.

  1. Obtain exact onset and systemic symptoms and perform corrected monocular acuity, colour, fields, pupils, fundi and a complete neurological and ocular-motor examination.
  2. Arrange same-day ophthalmic or neuro-ophthalmic assessment to exclude retinal vascular, giant-cell-arteritis, pressure and structural emergencies, sending ESR, CRP and platelets immediately when arteritis is possible.

Key medicines

High-dose methylprednisolone for selected demyelinating relapseWhen a neurologist or neuro-ophthalmologist recommends relapse treatment, use oral methylprednisolone 500 mg daily for five days, or intravenous methylprednisolone 1 g daily for three to five days when the NICE alternative criteria apply.
Open full textbook Answer 2 questions
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom